Sandbox testing: Difference between revisions
Jump to navigation
Jump to search
(Replaced content with "{{Label template}}") |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Label_template | ||
|drugClass=thienopyridine | |||
|indication=ACS | |||
|blackBoxWarning=Yes | |||
|adverseReactions= increased risk of bleeding | |||
}} |
Latest revision as of 20:25, 18 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]{{{authorTag}}}
For information about {{{genericName}}}, click here.
Disclaimer
Overview
Sandbox testing is a thienopyridine drug that is FDA approved for the treatment of ACS. Adverse reactions include increased risk of bleeding.